| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_ELP3_0002500 | Exon-Exon | chr8:27967887-27995408 | chr8:28110370-28137891 | 390 nt | 0.5000 |
| hsa_ELP3_0002600 | Exon-Exon | chr8:27967887-28013549 | chr8:28110370-28156032 | 91 nt | 0.4615 |
| hsa_ELP3_0002700 | Exon-Exon | chr8:27967916-28016150 | chr8:28110399-28158633 | 40 nt | 0.4250 |
| hsa_ELP3_0003100 | Exon-Exon | chr8:27970536-27989921 | chr8:28113019-28132404 | 133 nt | 0.4737 |
| hsa_ELP3_0003200 | Exon-Exon | chr8:27970536-27995408 | chr8:28113019-28137891 | 161 nt | 0.3665 |
| hsa_ELP3_0002900 | Exon-Exon | chr8:27970536-28013549 | chr8:28113019-28156032 | 729 nt | 0.4527 |
| hsa_ELP3_0003000 | Exon-Exon | chr8:27970536-28017973 | chr8:28113019-28160456 | 1023 nt | 0.4536 |
| hsa_ELP3_0003300 | Exon-Exon | chr8:27970536-28019595 | chr8:28113019-28162078 | 82 nt | 0.4634 |
| hsa_chr8_0287700 | Intergenic-Intergenic | chr8:27974617-27975823 | chr8:28117100-28118306 | 1207 nt | 0.3612 |
| hsa_ELP3_0003400 | Intron-Intron | chr8:27974723-27975995 | chr8:28117206-28118478 | 1273 nt | 0.3590 |
A study in human bladder cancer demonstrated that the circELP3 contributes to cancer progression and cisplatin resistance [Huang et al. DOI:10.3390/cells11091381].